Back to search

Belgium· BE-AMP-SAM193961-00

Infanrix IPV + Hib

A diphtherie-haemophilus-influenzae b-pertussis-poliomyelitis-tetanus product containing diphtheria toxoid (dt), registered in Belgium by GlaxoSmithKline Biologicals. The same ATC class is registered in 8 of our 19 countries.

ATC J07CA06

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedInfanrix IPV + HibATCJ07CA06REGISTER NO.BE-AMP-SAM193961-00PACKS LISTED0CHECKEDSeptember 26, 2026

Where it is registered

Diphtherie-haemophilus-influenzae b-pertussis-poliomyelitis-tetanus is registered in 8 of 19 countries.

Countries holding a registration under ATC J07CA06 (diphtherie-haemophilus-influenzae b-pertussis-poliomyelitis-tetanus), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 6 of them publish a price we can compare per daily dose

Diphtherie-haemophilus-influenzae b-pertussis-poliomyelitis-tetanus · ATC J07CA06

8 / 19 countries

  • Belgiumprice
  • Canada
  • Denmark
  • Finlandprice
  • Icelandprice
  • Polandprice
  • Spainprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Diphtheria Toxoid (DT)
Manufacturer
GlaxoSmithKline Biologicals
Country
Belgium (BE)
ATC code
J07CA06
ATC class
Diphtherie-Haemophilus-influenzae B-Pertussis-Poliomyelitis-Tetanus
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Diphtherie-haemophilus-influenzae b-pertussis-poliomyelitis-tetanus in 2 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All diphtherie-haemophilus-influenzae b-pertussis-poliomyelitis-tetanus products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c43725e8-2295-41be-b354-d556506ace58
GET /v1/drugs/c43725e8-2295-41be-b354-d556506ace58?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Powder and suspension for suspension for injection",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Infanrix IPV + Hib",
  "name_fr": "Infanrix IPV + Hib",
  "name_nl": "Infanrix IPV + Hib",
  "amp_code": "SAM193961-00",
  "strengths": [
    "30.0000",
    "40.0000",
    "8.0000",
    "25.0000",
    "32.0000",
    "8.0000",
    "25.0000",
    "40.0000",
    "12.6000",
    "4.5000"
  ],
  "pack_count": 2,
  "substances": [
    "Diphtheria Toxoid (DT)",
    "Poliovirus Type 1 (inactivated)",
    "Bordetella Pertussis Pertactin",
    "Bordetella Pertussis Toxoid (PT)",
    "Conjugate of Haemophilus influenzae type b capsular polysaccharide and Tetanus toxoid",
    "Poliovirus Type 3 (inactivated)",
    "Poliovirus Type 2 (inactivated)",
    "Bordetella Pertussis Filamentous Hemagglutinin (FHA)",
    "Tetanus Toxoid",
    "Lactose",
    "Sodium Chloride"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Diphtheria-Haemophilus Influenzae B-Pertussis-Poliomyelitis-Tetanus",
  "authorisation_numbers": [
    "BE193961"
  ]
}

See everything about diphtherie-haemophilus-influenzae b-pertussis-poliomyelitis-tetanus.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.